Related Experiment Video
Updated: Jul 18, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Percutaneous balloon mitral valvotomy in mitral restenosis
S Gupta1, A Vora, Y Lokhandwalla
1King Edward VII Memorial (KEM) Hospital, Bombay, India.
European Heart Journal
|October 1, 1996
Summary
Percutaneous balloon mitral valvotomy is a safe and effective treatment for mitral restenosis after surgery. Outcomes are comparable to initial procedures, with sustained benefits at intermediate-term follow-up.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Mitral restenosis commonly develops 5-15 years post-surgical valvotomy.
- Percutaneous balloon mitral valvotomy (PBMV) is an alternative to surgery for mitral stenosis.
- Limited data exists on PBMV for restenosis post-surgical valvotomy.
Purpose of the Study:
- Evaluate PBMV safety and efficacy in mitral restenosis patients.
- Assess intermediate-term outcomes of PBMV after prior surgical valvotomy.
- Compare PBMV outcomes in restenosis patients versus initial procedure patients.
Main Methods:
- Retrospective analysis of 614 PBMV patients.
- Group I: 84 patients with mitral restenosis post-surgical valvotomy.
- Group II: 530 patients without prior surgery; compared baseline characteristics and outcomes.
Main Results:
- Both groups showed comparable improvements in mitral valve area, transmitral gradient, and pulmonary artery pressure post-PBMV.
- Success rates were similar (93.0% vs 95.3%).
- Intermediate-term follow-up revealed sustained comparable functional class, valve area, and gradients.
Conclusions:
- PBMV is safe and effective for mitral restenosis post-surgical valvotomy.
- Acute outcomes are sustained at intermediate-term follow-up.
- Results are similar to PBMV performed as an initial procedure.
Related Concept Videos
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...